Skip to main content
Log in

Inhibition of fibrotic contraction by C-phycocyanin through modulation of connective tissue growth factor and α-smooth muscle actin expression

  • Original Article
  • Tissue Engineering
  • Published:
Tissue Engineering and Regenerative Medicine Aims and scope

Abstract

The effects of C-phycocyanin (C-pc), a phycobiliprotein, on the expression of pro-fibrotic mediators in hyper-tropic scarring such as connective tissue growth factor (CTGF) and α-smooth muscle actins (α-SMA) were investigated in relation to trans-differentiation of fibroblast to myo-fibroblast, an icon of scar formation. C-pc was isolated from Spirulina Platensis extract using sonication method and C-pc concentration was determined by Bennet and Bogorad equation. α-SMA and CTGF levels in wounded primary human dermal fibroblasts were determined by western blot analysis and immuno-fluorescence confocal microscope was employed. Fibroblast contractility was examined by three-dimensional collagen lattice contraction assay. There was an elevation of α-SMA (121%) and CTGF (143%) levels in wound cells as compared with non-wound cells. The does-response profiles of down regulation demonstrated that the maximum inhibitions of α-SMA by 63% (p<0.05) and CTGF by 50% (p<0.1) were achieved by C-pc (6 nM) treated cells. In confocal assay, non-wound fibroblasts exhibited basal level of α-SMA staining, while wounded cells without C-pc treatment showed strong up-regulation of α-SMA by 147% (p<0.05). C-pc (6 nM) inhibited α-SMA expression by 70% (p<0.05) and reduced collagen contraction by 29% (p<0.05). C-pc seemed to lessen the over expression of CTGF, α-SMA, subsequently alleviating the fibrotic contracture. This study suggests the potential application of C-pc to regulation of the expression of pro-fibrotic mediators in scarring process and its potential usage as an efficient means for anti-fibrosis therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007;127:514–525.

    Article  CAS  PubMed  Google Scholar 

  2. Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 2005;15:599–607.

    Article  CAS  PubMed  Google Scholar 

  3. Rinkevich Y, Walmsley GG, Hu MS, Maan ZN, Newman AM, Drukker M, et al. Skin fibrosis. Identification and isolation of a dermal lineage with intrinsic fibrogenic potential. Science 2015;348:aaa2151.

    Article  PubMed  Google Scholar 

  4. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738–746.

    Article  CAS  PubMed  Google Scholar 

  5. Seo YC, Choi WS, Park JH, Park JO, Jung KH, Lee HY. Stable isolation of phycocyanin from Spirulina platensis associated with high-pressure extraction process. Int J Mol Sci 2013;14:1778–1787.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ou Y, Zheng S, Lin L, Jiang Q, Yang X. Protective effect of C-phycocyanin against carbon tetrachloride-induced hepatocyte damage in vitro and in vivo. Chem Biol Interact 2010;185:94–100.

    Article  CAS  PubMed  Google Scholar 

  7. Romay C, González R. Phycocyanin is an antioxidant protector of human erythrocytes against lysis by peroxyl radicals. J Pharm Pharmacol 2000;52:367–368.

    Article  CAS  PubMed  Google Scholar 

  8. Vadiraja BB, Gaikwad NW, Madyastha KM. Hepatoprotective effect of C-phycocyanin: protection for carbon tetrachloride and R-(+)-pulegone-mediated hepatotoxicty in rats. Biochem Biophys Res Commun 1998;249:428–431.

    Article  CAS  PubMed  Google Scholar 

  9. Romay Ch, González R, Ledón N, Remirez D, Rimbau V. C-phycocyanin: a biliprotein with antioxidant, anti-inflammatory and neuroprotec tive effects. Curr Protein Pept Sci 2003;4:207–216.

    Article  CAS  PubMed  Google Scholar 

  10. Su WH, Cheng MH, Lee WL, Tsou TS, Chang WH, Chen CS, et al. Nonsteroidal anti-inflammatory drugs for wounds: pain relief or excessive scar formation? Mediators Inflamm 2010;2010:413238.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Reddy CM, Bhat VB, Kiranmai G, Reddy MN, Reddanna P, Madyastha KM. Selective inhibition of cyclooxygenase-2 by C-phycocyanin, a biliprotein from Spirulina platensis. Biochem Biophys Res Commun 2000;277:599–603.

    Article  CAS  PubMed  Google Scholar 

  12. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007;127:526–537.

    Article  CAS  PubMed  Google Scholar 

  13. Thannickal VJ, Lee DY, White ES, Cui Z, Larios JM, Chacon R, et al. Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J Biol Chem 2003;278:12384–12389.

    Article  CAS  PubMed  Google Scholar 

  14. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. Alphasmooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 2001;12:2730–2741.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003;200:500–503.

    Article  CAS  PubMed  Google Scholar 

  16. Desai VD, Hsia HC, Schwarzbauer JE. Reversible modulation of myofibroblast differentiation in adipose-derived mesenchymal stem cells. PLoS One 2014;9:e86865.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Evans RA, Tian YC, Steadman R, Phillips AO. TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. Exp Cell Res 2003;282:90–100.

    Article  CAS  PubMed  Google Scholar 

  18. Yang M, Huang H, Li J, Huang W, Wang H. Connective tissue growth factor increases matrix metalloproteinase-2 and suppresses tissue inhibitor of matrix metalloproteinase-2 production by cultured renal interstitial fibroblasts. Wound Repair Regen 2007;15:817–824.

    Article  PubMed  Google Scholar 

  19. Alfaro MP, Deskins DL, Wallus M, DasGupta J, Davidson JM, Nanney LB, et al. A physiological role for connective tissue growth factor in early wound healing. Lab Invest 2013;93:81–95.

    Article  CAS  PubMed  Google Scholar 

  20. Garrison G, Huang SK, Okunishi K, Scott JP, Kumar Penke LR, Scruggs AM, et al. Reversal of myofibroblast differentiation by prostaglandin E(2). Am J Respir Cell Mol Biol 2013;48:550–558.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Maher TM, Evans IC, Bottoms SE, Mercer PF, Thorley AJ, Nicholson AG, et al. Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010;182:73–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Pardhasaradhi BV, Ali AM, Kumari AL, Reddanna P, Khar A. Phycocyanin-mediated apoptosis in AK-5 tumor cells involves down-regulation of Bcl-2 and generation of ROS. Mol Cancer Ther 2003;2:1165–1170.

    CAS  PubMed  Google Scholar 

  23. Madhyastha HK, Radha KS, Nakajima Y, Omura S, Maruyama M. uPA dependent and independent mechanisms of wound healing by C-phycocyanin. J Cell Mol Med 2008;12(6B):2691–2703.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Bennett A, Bogorad L. Complementary chromatic adaptation in a filamentous blue-green alga. J Cell Biol 1973;58:419–435.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Moon H, Yong H, Lee AR. Optimum scratch assay condition to evaluate connective tissue growth factor expression for anti-scar therapy. Arch Pharm Res 2012;35:383–388.

    Article  CAS  PubMed  Google Scholar 

  26. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004;9:283–289.

    Article  CAS  PubMed  Google Scholar 

  27. Huxlin KR, Hindman HB, Jeon KI, Bühren J, MacRae S, DeMagistris M, et al. Topical rosiglitazone is an effective anti-scarring agent in the cornea. PLoS One 2013;8:e70785.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Igarashi A, Okochi H, Bradham DM, Grotendorst GR. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993;4:637–645.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Reish RG, Eriksson E. Scars: a review of emerging and currently available therapies. Plast Reconstr Surg 2008;122:1068–1078.

    Article  CAS  PubMed  Google Scholar 

  30. Madhyastha H, Madhyastha R, Nakajima Y, Omura S, Maruyama M. Regulation of growth factors-associated cell migration by C-phycocyanin scaffold in dermal wound healing. Clin Exp Pharmacol Physiol 2012;39:13–19.

    Article  CAS  PubMed  Google Scholar 

  31. Kalinski P. Regulation of immune responses by prostaglandin E2. J Immunol 2012;188:21–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ae-Ri Cho Lee.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

An, E., Park, H. & Lee, AR.C. Inhibition of fibrotic contraction by C-phycocyanin through modulation of connective tissue growth factor and α-smooth muscle actin expression. Tissue Eng Regen Med 13, 388–395 (2016). https://doi.org/10.1007/s13770-015-0104-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13770-015-0104-5

Key Words

Navigation